Biopharma Quarterly Dealmaking Statistics, Q4 2014
A look at financing, M&A, and alliance activity October–December 2014
Executive Summary
Biopharma financing increased 53% in Q4 to $8.8 billion; Actavis’ $65 billion takeover of Allergan topped the M&A activity, and Janssen led in dealmaking with six alliances.